---
title: "Bowen Acquisition | 10-Q: FY2025 Q2 EPS: USD 0.22"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253265998.md"
datetime: "2025-08-15T20:32:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253265998.md)
  - [en](https://longbridge.com/en/news/253265998.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253265998.md)
generator: "portal-rs"
---

# Bowen Acquisition | 10-Q: FY2025 Q2 EPS: USD 0.22

EPS: As of FY2025 Q2, the actual value is USD 0.22.

### Segment Revenue

-   The company has not generated any operating revenues as of June 30, 2025, as it is still in the process of identifying a target for its initial business combination.

### Operational Metrics

-   For the three months ended June 30, 2025, the company reported a net income of $750,303, compared to a net income of $816,754 for the same period in 2024.
-   For the six months ended June 30, 2025, the company reported a net loss of - $1,289,691, compared to a net income of $1,603,116 for the same period in 2024.
-   Operating costs for the three months ended June 30, 2025, were $76,828, and for the six months ended June 30, 2025, were $211,563.

### Cash Flow

-   Net cash used in operating activities for the six months ended June 30, 2025, was - $86,218.
-   Cash and cash equivalents as of June 30, 2025, were $17,556, down from $103,774 as of December 31, 2024.

### Unique Metrics

-   The company recorded a loss on issuance of FPA liability of - $1,929,656 and a gain from the change in fair value of FPA liability of $1,123,154 for the six months ended June 30, 2025.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focused on completing its initial business combination, with a proposed merger involving Shenzhen Qianzhi BioTechnology Co. Ltd. The company has extended the deadline for completing this business combination to December 14, 2025.
-   **Non-Core Business**: The company has entered into a Prepaid Forward Purchase Agreement to manage share redemptions and maintain liquidity during the business combination process.
-   **Priority**: The company is prioritizing the completion of its business combination within the extended timeframe to avoid liquidation and dissolution.

### Related Stocks

- [BOWN.US](https://longbridge.com/en/quote/BOWN.US.md)

## Related News & Research

- [AMD May Have Found Its Next Big AI Growth Engine](https://longbridge.com/en/news/296950025.md)
- [Intuit Stock Falls Ahead of Q4 Earnings: What Investors Need to Know](https://longbridge.com/en/news/296933970.md)
- [Anthropic expected to tell investors it sees over $30 trillion in potential revenue, WSJ reports](https://longbridge.com/en/news/296941513.md)
- [Bankers are shopping Hugging Face at triple the price it gave Nvidia](https://longbridge.com/en/news/296947134.md)
- [Wearable Devices Files First-Half 2026 Results and Corporate Update](https://longbridge.com/en/news/296836359.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**